Considerations for use of Real-World Evidence in oncology: lessons learned from Friends of Cancer Research collaborations Published October 2020 Citation Baxi, SS, Cohen, AB, Mahoney, N, Rasmussen, E, Tymejczyk, O, Torres, AZ. . Friends of Cancer Research. . https://friendsofcancerresearch.org/sites/default/files/2020-10/Use_of_Real-World_Evidence_in_Oncology-2020.pdf Authors:Baxi, SS, Cohen, AB, Mahoney, N, Rasmussen, E, Tymejczyk, O, Torres, AZ Sources:Friends of Cancer Research Share Posted inPublicationsMethodologyNon-small cell lung cancer More publicationsISPORApril 2025Analytical approaches to estimate medication persistence from EHR data: a study of TKIs in patients with EGFR+ advanced NSCLCLi X, Jarrett B, Kerr B, et al. Real-world evidencePublication summaryPublicationsMethodologyNon-small cell lung cancerASCO Annual MeetingMay 2026Drivers of organotropism and patterns of metastatic progression in metastatic non-small cell lung cancerPublication summaryPublicationsNon-small cell lung cancerASCO Annual MeetingMay 2026Machine learning risk stratification in a US-based database to identify subgroups of patients with PD-L1-high NSCLC who benefit from adding chemotherapy to pembrolizumabOrcutt X, Nimgaonkar V, Sun L, et al.Publication summaryPublicationsMachine learningComparative effectivenessNon-small cell lung cancerArtificial intelligence